Clinical Trials in Boston

Showing 7161-7180 of 13,548 trials

Olfactory Deficits in Neurologic Disease

NCT05019014

The goal of this study is to examine olfactory function in preclinical subjects or individuals with neurological diseases such as Probable Alzheimer's Disease (PRAD), Frontotemporal Dementias (FTD), Dementia with Lewy Bodies (DLB), Traumatic Brain Injury (TBI), and Amyotrophic Lateral Sclerosis (ALS).

Alzheimer DiseaseTraumatic Brain InjuryAmyotrophic Lateral Sclerosis+3 more

Massachusetts General Hospital201 participantsStarted Aug 2011

Boston, Massachusetts, United States

WITHDRAWNPhase 4< 1 mile

A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

NCT04864977

The main purpose of this study is to evaluate a novel approach for insulin glargine (LY2963016) titration for insulin-naïve adults with type 2 diabetes (T2D) The study will last about 6 months.

Type 2 DiabetesType 2 Diabetes Treated With Insulin

Eli Lilly and CompanyStarted Aug 2021

Boston, Massachusetts, United States

COMPLETED< 1 mile

St.Jude Medical Cardiac Lead Assessment Study

NCT01507987

The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized, multi-center, international postmarket surveillance study under 522 Order PS120111 (August 16, 2012).

Externalized ConductorsVisual Lead AnomaliesElectrical Dysfunction

Abbott Medical Devices2,216 participantsStarted Mar 2013

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +42 more locations

Olfactory Deficits in Neurologic Disease

A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

St.Jude Medical Cardiac Lead Assessment Study

Find Trials by Condition in Boston

Novel Social Media Intervention For Older Br CA Patients

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

HMB- Data Collection Methods

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901

PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer

R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma

An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis